CHILDRENS MEDICINES
September 1st, 2005
BY KEITH NUTHALLTHE EUROPEAN Parliament has rejected calls for large pharmaceutical companies to be refused proposed additional patent rights for developing children's medicines. It approved a European Union (EU) regulation that would give all manufacturers six more months of patent protection for child medicines over and above what they currently enjoy. Françoise Grossetête, the French conservative MEP coordinating the parliament's votes on the legislation condemned varying patent extensions according to company size as "leading us from the logic of health to ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.